Skip to main content
NoticePayment processing is currently down, so we are not taking new orders right now. Thank you for your patience.
For laboratory research use only. Not for human or veterinary use.
Free UPS Ground on 3+ vials · same business day by 2 PM ET
BPC-157 + TB-500Preclinical

Thymosin beta 4 promotes corneal wound healing and decreases inflammation in vivo following alkali injury

Sosne G, Szliter EA, Barrett R, et al. · Exp Eye Res · 2002
PMID: 11950239 · DOI: 10.1006/exer.2002.1170
Summary

In vivo mouse model of corneal alkali injury characterizing topical thymosin beta 4 vs vehicle. Endpoints: re-epithelialization rate, polymorphonuclear leukocyte infiltration, inflammatory cytokine mRNA.

Read the full citation on PubMed

Citation hosted by NCBI. We link to the source so the researcher can read the abstract, full text, or references-cited list directly.

Compounds referenced in this study
  • TB-500 (Long Chain)
    Synthetic acetylated thymosin-β4 (1-43) analog. Studied in tissue-regeneration research.
    View product →
Guides covering this compound
More BPC-157 + TB-500 citations
Browse the catalog